Overall rank by patents
#40,810
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, active 2015–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR).
The verdict
Icepipe holds 6 US patents across 3 technology areas, rank #40,810 of 50,000 tracked assignees.
Icepipe Corporation has been granted 6 US utility patents between 2015 and 2017, placing Icepipe Corporation at rank #40,810 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 3.5 claims per patent with primary concentration in H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR). As a Foreign Corporation, Icepipe Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Icepipe sits between I2 Pharmaceuticals, Inc. (6 patents, rank #40,806) and ICN Acquisition, Llc (6 patents, rank #40,814) - the closest US assignees by grant volume. The composite Innovation Score of 14.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 6 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Icepipe Corporation's 3.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Icepipe Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
I2 PHARMACEUTICALS, INC.
6 patents
IAP WORLDWIDE SERVICES, INC.
6 patents
ICAN COMPANY LTD.
6 patents
ICE Edge Business Solutions, Ltd.
6 patents
ICEpower A/S
6 patents
ICHARTS, INC.
6 patents
ICM (Institut Du Cerveau Et De La Moellle Épiniére)
6 patents
ICN ACQUISITION, LLC
6 patents
ICEPIPE CORPORATION
6 patents
What this shows Icepipe holds 6 patents at rank #40,810, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,810 in granted patent volume.
Other assignees with the most granted patents in Icepipe's primary technology class.
Icepipe's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
15 Top 97% higher than 3% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 50.0% |
| 2016 | 2 | 33.3% |
| 2017 | 1 | 16.7% |
Top 3 of 3 technology areas
Overall rank by patents
#40,810
Across all tracked assignees
14.9 out of 100
How to use this portfolio
Icepipe's 6 grants land it in the top 97% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.